AlphaCentric Advisors »

Teradyne shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Teradyne (TER) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Teradyne

Tip: Access up to 7 years of quarterly data

All positions including Teradyne held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teradyne by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $67k 138 483.84
2023-09-30 $754k 7.5k 100.46

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Vertex Pharmaceuticals Incorporated (VRTX)
Invitation Homes (INVH)
Astrazeneca Ord (AZN)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Axsome Therapeutics (AXSM)
Apogee Therapeutics (APGE)
Euronet Worldwide (EEFT)
Aeva Technologies Com New (AEVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for AlphaCentric Advisors

Top funds holding Teradyne

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Geode Capital Management
FMR
Ameriprise Financial
Alkeon Capital Management
Invesco
Van Eck Associates Corp.
Point72 Asset Management
AQR Capital Management
Morgan Stanley
Susquehanna International
T. Rowe Price Associates

View all funds holding Teradyne